NewsRx

Search our medical news database

Photocatalytics

New Findings in Photocatalytics Described from University of Kagoshima

Published in Cancer Weekly, January 31st, 2012

2012 JAN 31 -- Current study results from the report, "Synergistic enhanced photocatalytic and photothermal activity of Au@TiO2 nanopellets against human epithelial carcinoma cells," have been published. "The photocatalytic and plasmonic photothermal cancer cell-killing activity of the metallic Au-capped TiO(2) (Au@TiO(2)) composite colloidal nanopellets has been investigated on HeLa cells under UV-visible (350-600 nm) light irradiation. The Au@TiO(2) composite nanopellets with the uniform Au-capped TiO(2) structure were successfully synthesized by simple reduction of HAuCl(4) on the surface of TiO(2) nanoparticles," scientists writing in the journal Physical Chemistry...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook